Big Move For Jupiter Neurosciences, Inc.
Thu, Jul 03, 2025 at 07:20 PM
Jupiter Neurosciences, Inc. (JUNS:NASDAQ) jumped higher at $1.65, a gain of 38.7%. On Thu, Jul 03, 2025, JUNS:NASDAQ hit a New 2-Week High of $1.65. The stock appeared on our News Catalysts scanner on Fri, Jun 27, 2025 at 10:32 AM in the 'PATENT' category. From Fri, Jun 20, 2025, the stock recorded 33.33% Up Days and 30.00% Green Days
The stock spiked on Wed, Jun 11, 2025 at $2.29 with a volume of 9M+.
About Jupiter Neurosciences, Inc. (JUNS:NASDAQ)
Jupiter Neurosciences is a clinical stage research and development pharmaceutical company. The Company has developed a unique resveratrol platform product targeting treatment of neuro-inflammation.
Top 10 Gainers:
- Global Interactive Technologies, Inc. (GITS:NASDAQ), 135.58%
- Regencell Bioscience Holdings Limited (RGC:NASDAQ), 121.91%
- La Rosa Holdings Corp. (LRHC:NASDAQ), 87.27%
- Enigmatig Limited Class A (EGG:NYSEMKT), 53.51%
- Wolfspeed, Inc. (WOLF:NYSE), 52.63%
- Eyenovia, Inc. (EYEN:NASDAQ), 49.81%
- Jupiter Neurosciences, Inc. (JUNS:NASDAQ), 38.66%
- Theratechnologies Inc. (THTX:NASDAQ), 35.59%
- Xponential Fitness, Inc. (XPOF:NYSE), 35.39%
- Vor Biopharma Inc. (VOR:NASDAQ), 31.72%